Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies.

Kimbrel EA, Lanza R.

Regen Med. 2015;10(2):99-102. doi: 10.2217/rme.14.89. No abstract available.

2.

Transdifferentiation of Human Hair Follicle Mesenchymal Stem Cells into Red Blood Cells by OCT4.

Liu Z, Lu SJ, Lu Y, Tan X, Zhang X, Yang M, Zhang F, Li Y, Quan C.

Stem Cells Int. 2015;2015:389628. doi: 10.1155/2015/389628.

3.

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.

Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R.

Lancet. 2015 Feb 7;385(9967):509-16. doi: 10.1016/S0140-6736(14)61376-3.

PMID:
25458728
4.

Scalable generation of universal platelets from human induced pluripotent stem cells.

Feng Q, Shabrani N, Thon JN, Huo H, Thiel A, Machlus KR, Kim K, Brooks J, Li F, Luo C, Kimbrel EA, Wang J, Kim KS, Italiano J, Cho J, Lu SJ, Lanza R.

Stem Cell Reports. 2014 Nov 11;3(5):817-31. doi: 10.1016/j.stemcr.2014.09.010.

5.

Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis.

Wang X, Kimbrel EA, Ijichi K, Paul D, Lazorchak AS, Chu J, Kouris NA, Yavanian GJ, Lu SJ, Pachter JS, Crocker SJ, Lanza R, Xu RH.

Stem Cell Reports. 2014 Jun 6;3(1):115-30. doi: 10.1016/j.stemcr.2014.04.020.

6.

Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategies.

Park H, Kim D, Kim CH, Mills RE, Chang MY, Iskow RC, Ko S, Moon JI, Choi HW, Man Yoo PS, Do JT, Han MJ, Lee EG, Jung JK, Zhang C, Lanza R, Kim KS.

Stem Cells Transl Med. 2014 May;3(5):599-609. doi: 10.5966/sctm.2013-0149.

7.

Human somatic cell nuclear transfer using adult cells.

Chung YG, Eum JH, Lee JE, Shim SH, Sepilian V, Hong SW, Lee Y, Treff NR, Choi YH, Kimbrel EA, Dittman RE, Lanza R, Lee DR.

Cell Stem Cell. 2014 Jun 5;14(6):777-80. doi: 10.1016/j.stem.2014.03.015.

8.

Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties.

Kimbrel EA, Kouris NA, Yavanian GJ, Chu J, Qin Y, Chan A, Singh RP, McCurdy D, Gordon L, Levinson RD, Lanza R.

Stem Cells Dev. 2014 Jul 15;23(14):1611-24. doi: 10.1089/scd.2013.0554.

9.

3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected].

Lu SJ, Kelley T, Feng Q, Chen A, Reuveny S, Lanza R, Oh SK.

Regen Med. 2013 Jul;8(4):413-24. doi: 10.2217/rme.13.36. Erratum in: Regen Med. 2013 Sep;8(5):672.

PMID:
23826696
10.

Embryonic stem cells from blastomeres maintaining embryo viability.

Klimanskaya I.

Semin Reprod Med. 2013 Jan;31(1):49-55. doi: 10.1055/s-0032-1331797. Review.

PMID:
23329636
11.

The Promise and Therapeutic Potential of Human ES and iPS Cells.

Lu SJ, Lee RJ, Napoli C, Oh S, Kimbrel EA, Feng Q.

Stem Cells Int. 2011;2011:959275. doi: 10.4061/2011/959275. No abstract available.

12.

Stomping out barriers for hRBC mouse models.

Kimbrel EA, Lanza R.

Blood. 2011 Nov 24;118(22):5719-20. doi: 10.1182/blood-2011-09-381152. No abstract available.

13.

Tetraspanin, CD151, is required for maintenance of trigeminal placode identity.

McCabe KL, Bronner M.

J Neurochem. 2011 Apr;117(2):221-30. doi: 10.1111/j.1471-4159.2011.07190.x.

14.

Directed differentiation of red blood cells from human embryonic stem cells.

Lu SJ, Feng Q, Park JS, Lanza R.

Methods Mol Biol. 2010;636:105-21. doi: 10.1007/978-1-60761-691-7_7.

PMID:
20336519
15.

Reprogramming of human somatic cells using human and animal oocytes.

Chung Y, Bishop CE, Treff NR, Walker SJ, Sandler VM, Becker S, Klimanskaya I, Wun WS, Dunn R, Hall RM, Su J, Lu SJ, Maserati M, Choi YH, Scott R, Atala A, Dittman R, Lanza R.

Cloning Stem Cells. 2009 Jun;11(2):213-23. doi: 10.1089/clo.2009.0004.

PMID:
19186982
16.

Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells.

Lu SJ, Ivanova Y, Feng Q, Luo C, Lanza R.

Regen Med. 2009 Jan;4(1):37-47. doi: 10.2217/17460751.4.1.37.

PMID:
19105615
17.

Robust generation of hemangioblastic progenitors from human embryonic stem cells.

Lu SJ, Luo C, Holton K, Feng Q, Ivanova Y, Lanza R.

Regen Med. 2008 Sep;3(5):693-704. doi: 10.2217/17460751.3.5.693.

18.

Biologic properties and enucleation of red blood cells from human embryonic stem cells.

Lu SJ, Feng Q, Park JS, Vida L, Lee BS, Strausbauch M, Wettstein PJ, Honig GR, Lanza R.

Blood. 2008 Dec 1;112(12):4475-84. doi: 10.1182/blood-2008-05-157198.

19.

Stem cells and cardiac repair: a critical analysis.

Dinsmore JH, Dib N.

J Cardiovasc Transl Res. 2008 Mar;1(1):41-54. doi: 10.1007/s12265-007-9008-7. Review.

PMID:
20559957
20.

Efficient differentiation of functional hepatocytes from human embryonic stem cells.

Agarwal S, Holton KL, Lanza R.

Stem Cells. 2008 May;26(5):1117-27. doi: 10.1634/stemcells.2007-1102.

Items per page

Supplemental Content

Loading ...
Support Center